South Miami

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Coronary artery disease1 trial
• Rheumatoid arthritis1 trial
• Systemic sclerosis (scleroderma)1 trial

Phase

• Phase 32 trials
• Phase 21 trial

Status

• Active, not recruiting1 trial
• Suspended1 trial
• Withdrawn1 trial

Lead sponsor

• AstraZeneca2 trials
• DalCor Pharmaceuticals1 trial

Running trials

• Active, not recruiting

  Determine Effectiveness of Anifrolumab In SYstemic Sclerosis (DAISY)

  NCT05925803· Phase 3· AstraZeneca· Source

Closed trials

• Recruiting

  Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS

  NCT05918861· Phase 3· DalCor Pharmaceuticals· Source

  Contact: David Kallend, MBBS